RC
IDXX icon

Rexford Capital’s Idexx Laboratories IDXX Stock Holding History

Rexford Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161K Hold
305
– – 0.1% 190
2026
Q1 		$171K Hold
305
– – 0.12% 181
2025
Q4 		$206K Hold
305
– – 0.16% 161
2025
Q3 		$195K Hold
305
– – 0.15% 167
2025
Q2 		$164K Buy
+305
New +$146K 0.14% 179

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Rexford Capital's IDXX Position: Q2 2026 in Review

Rexford Capital held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 305 shares worth $161K. The position accounts for 0.1% of the portfolio, ranked #190.

Rexford Capital first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $206K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Rexford Capital held 305 shares of Idexx Laboratories worth $161K as of Q2 2026.
  • Rexford Capital left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.1% of Rexford Capital's portfolio in Q2 2026, its #190 holding.
  • Rexford Capital first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Rexford Capital's Idexx Laboratories position peaked at $206K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.